Dechra Pharmaceuticals PLC Additional Listing (4808T)
March 21 2019 - 2:02AM
UK Regulatory
TIDMDPH
RNS Number : 4808T
Dechra Pharmaceuticals PLC
21 March 2019
21 March 2019
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Additional Listing
An application for admission to the Premium Segment of the
Official List has been made to the Financial Conduct Authority and
the London Stock Exchange for an increase of 69,468 ordinary shares
of 1 pence each in relation to the existing block listing (the
"Shares") for the Company's following schemes:
-- Unapproved Share Option Scheme: 26,140
-- Approved Share Option Scheme: 8,328
-- Long-Term Incentive Scheme: 35,000
These Shares will rank pari passu with the Company's existing
shares in issue. It is expected that admission will become
effective on 22 March 2019.
For further information, please contact:
Dechra Pharmaceuticals PLC
Melanie Hall, Company Secretary
Telephone number: +44 (0) 1606 814730
Email: corporate.enquiries@dechra.com
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. The majority of Dechra's
products are focused on key therapeutic categories where we have
leading market positions, and many of our products are used to
treat medical conditions for which there is no other effective
solution or have a clinical or dosing advantage over competitor
products. For more information, please visit: www.dechra.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ALSLLFISVAIIFIA
(END) Dow Jones Newswires
March 21, 2019 03:02 ET (07:02 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024